Hypothesis

Aging increases mitochondrial reactive oxygen species (ROS) in substantia nigra dopaminergic neurons, which activates the NLRP3 inflammasome and releases interleukin‑1β (IL‑1β) into the striatal extracellular space. This cytokine milieu preferentially affects D1/D2 co‑expressing medium spiny neurons, shifting their intracellular signaling toward a pro‑inflammatory ERK1/2/MAPK state that drives spine loss and deafferentation. The resulting imbalance in glutamatergic output from these neurons amplifies basal ganglia‑SCAN hyperconnectivity, manifesting as early habit‑formation deficits before measurable dopamine depletion.

Mechanistic Rationale

1. Mitochondrial ROS is a well‑established upstream activator of NLRP3 in dopaminergic cells [5].
2. NLRP3‑derived IL‑1β can modulate MAPK signaling in striatal neurons, mirroring the D1 supersensitivity shift to ERK1/2/MAPK observed after denervation [2].
3. D1/D2 co‑expressing spiny neurons exhibit heightened vulnerability to inflammatory mediators, showing accelerated spine loss during dopamine loss [3].
4. Aberrant glutamatergic release from these neurons has been linked to pathological synchrony between basal ganglia and cortical networks such as SCAN [4].

Testable Predictions

• In aged mice, mitochondrial ROS levels in dopaminergic terminals will correlate with NLRP3 activation markers (e.g., ASC speck formation) and striatal IL‑1β concentrations.
• Selective inhibition of NLRP3 (e.g., MCC950) in aged animals will preserve spine density on D1/D2 co‑expressing neurons and normalize basal ganglia‑SCAN functional connectivity measured by resting‑state fMRI.
• Habit‑learning performance (e.g., instrumental conditioning with outcome devaluation) will decline in aged mice concomitant with the above biomarkers, and this decline will be rescued by NLRP3 blockade without restoring dopamine levels.
• Chemogenetic silencing of D1/D2 co‑expressing neurons will replicate SCAN hyperconnectivity and habit deficits in young mice, indicating their sufficiency.

Potential Experiments

• Use MitoSOX imaging and flow cytometry to quantify ROS in TH+ neurons from young (3 mo) and aged (18 mo) mice.
• Perform immunoblot for cleaved caspase‑1 and ELISA for IL‑1β in striatal homogenates; correlate with phospho‑ERK1/2 levels in FACS‑sorted D1/D2 co‑expressing neurons (identified via Drd1a‑Cre;Drd2‑Flp intersectional reporters).
• Treat aged mice with MCC950 or vehicle for 4 weeks; assess spine density via Golgi‑CoX staining and in‑vivo two‑photon imaging of dendritic spines in D1/D2 co‑expressing neurons.
• Acquire resting‑state fMRI to quantify functional connectivity between basal ganglia nodes and SCAN regions; compare across groups.
• Conduct instrumental lever‑press training followed by outcome devaluation to measure habit vs goal‑directed behavior; compute a habit index.
• Validate causality by expressing hM4D_i DREADDs selectively in D1/D2 co‑expressing neurons (using intersectional Cre/Flp) and administering CNO to test whether acute silencing reproduces the aged phenotype in young mice.

If these predictions hold, the data would support a mechanistic link between mitochondrial ROS/NLRP3 signaling in dopaminergic neurons, inflammatory re‑programming of D1/D2 co‑expressing striatal neurons, and early circuit‑level dysconnectivity that drives habit decline preceding dopaminergic loss.